INTERNATIONAL PATENT: LEVICEPT LIMITED FILES APPLICATION FOR "INJECTABLE FORMULATION"

GENEVA, Dec. 29 -- LEVICEPT LIMITED (Innovation HouseDiscovery ParkSandwich Kent CT13 9ND) filed a patent application (PCT/GB2025/051363) for "INJECTABLE FORMULATION" on Jun 19, 2025. With publication no. WO/2025/262427, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WESTBROOK, Simon (C/O Levicept LimitedInnovation HouseDiscovery ParkSandwich Kent CT13 9ND)

Abstract: A pharmaceutically acceptable formulation comprising a glycosylated p75NTR neurotrophin binding protein (NBP)-Fc fusion protein; a buffering agent; a stabi...